| Aug 26 |
IO Biotech Announces Participation in Upcoming Investor Conferences
|
| Aug 13 |
IO Biotech GAAP EPS of -$0.31
|
| Aug 13 |
IO Biotech Reports Second Quarter 2024 Financial Results and Provides Business Highlights
|
| Jul 25 |
IO Biotech Announces New Head and Neck Cohort Data Accepted for Presentation at ESMO Congress 2024
|
| Jul 21 |
IO Biotech, Inc.'s (NASDAQ:IOBT) market cap touched US$104m last week, benefiting both private equity firms who own 59% as well as institutions
|
| Jul 4 |
3 Undervalued Biotech Gems With 200%+ Analyst Price Targets
|
| May 27 |
Will IO Biotech (NASDAQ:IOBT) Spend Its Cash Wisely?
|
